Kaleta J - Search Results

1

3-Acylamino-azetidin-2-one as a novel class of cysteine proteases inhibitors.

Zhou NE, Guo D, Thomas G, Reddy AV, Kaleta J, Purisima E, Menard R, Micetich RG, Singh R. Zhou NE, et al. Among authors: kaleta j. Bioorg Med Chem Lett. 2003 Jan 6;13(1):139-41. doi: 10.1016/s0960-894x(02)00831-4. Bioorg Med Chem Lett. 2003. PMID: 12467634

2

Design and synthesis of 6-substituted amino-4-oxa-1-azabicyclo[3,2,0]heptan-7-one derivatives as cysteine proteases inhibitors.

Zhou NE, Guo D, Kaleta J, Purisima E, Menard R, Micetich RG, Singh R. Zhou NE, et al. Among authors: kaleta j. Bioorg Med Chem Lett. 2002 Dec 2;12(23):3413-5. doi: 10.1016/s0960-894x(02)00765-5. Bioorg Med Chem Lett. 2002. PMID: 12419373

3

6-Acylamino-penam derivatives: synthesis and inhibition of cathepsins B, L, K, and S.

Zhou NE, Kaleta J, Purisima E, Menard R, Micetich RG, Singh R. Zhou NE, et al. Among authors: kaleta j. Bioorg Med Chem Lett. 2002 Dec 2;12(23):3417-9. doi: 10.1016/s0960-894x(02)00766-7. Bioorg Med Chem Lett. 2002. PMID: 12419374

4

Potent inhibitors of cysteine proteases from the marine fungus Microascus longirostris.

Yu CM, Curtis JM, Walter JA, Wright JL, Ayer SW, Kaleta J, Querengesser L, Fathi-Afshar ZR. Yu CM, et al. Among authors: kaleta j. J Antibiot (Tokyo). 1996 Apr;49(4):395-7. doi: 10.7164/antibiotics.49.395. J Antibiot (Tokyo). 1996. PMID: 8642005 Free article. No abstract available.

5

Leupeptazin, a highly modified tripeptide isolated from cultures of a Streptomyces sp. inhibits cathepsin K.

Kruglyak N, Williams DE, Chen H, Law S, Kaleta J, Villanueva I, Davies JE, Andersen RJ, Brömme D. Kruglyak N, et al. Among authors: kaleta j. Bioorg Med Chem Lett. 2017 Mar 15;27(6):1397-1400. doi: 10.1016/j.bmcl.2017.02.007. Epub 2017 Feb 5. Bioorg Med Chem Lett. 2017. PMID: 28228366

6

Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design.

Lecaille F, Kaleta J, Brömme D. Lecaille F, et al. Among authors: kaleta j. Chem Rev. 2002 Dec;102(12):4459-88. doi: 10.1021/cr0101656. Chem Rev. 2002. PMID: 12475197 Review. No abstract available.

7

The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics.

Yasuda Y, Kaleta J, Brömme D. Yasuda Y, et al. Among authors: kaleta j. Adv Drug Deliv Rev. 2005 May 25;57(7):973-93. doi: 10.1016/j.addr.2004.12.013. Epub 2005 Apr 15. Adv Drug Deliv Rev. 2005. PMID: 15876399 Review.

8

Thiol-dependent cathepsins: pathophysiological implications and recent advances in inhibitor design.

Brömme D, Kaleta J. Brömme D, et al. Among authors: kaleta j. Curr Pharm Des. 2002;8(18):1639-58. doi: 10.2174/1381612023394179. Curr Pharm Des. 2002. PMID: 12132996 Review.

9

Selective inhibition of the collagenase activity of cathepsin K.

Selent J, Kaleta J, Li Z, Lalmanach G, Brömme D. Selent J, et al. Among authors: kaleta j. J Biol Chem. 2007 Jun 1;282(22):16492-501. doi: 10.1074/jbc.M700242200. Epub 2007 Apr 10. J Biol Chem. 2007. PMID: 17426030 Free article.

10

Affinity Crystallography: A New Approach to Extracting High-Affinity Enzyme Inhibitors from Natural Extracts.

Aguda AH, Lavallee V, Cheng P, Bott TM, Meimetis LG, Law S, Nguyen NT, Williams DE, Kaleta J, Villanueva I, Davies J, Andersen RJ, Brayer GD, Brömme D. Aguda AH, et al. Among authors: kaleta j. J Nat Prod. 2016 Aug 26;79(8):1962-70. doi: 10.1021/acs.jnatprod.6b00215. Epub 2016 Aug 6. J Nat Prod. 2016. PMID: 27498895

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters